Stocks and Investing Stocks and Investing
Mon, September 21, 2009
Sun, September 20, 2009
Fri, September 18, 2009
Thu, September 17, 2009

51.01% Of All NASDAQ Trading Wednesday Was Short Selling. MITI, PRVT, LAVA, ADAT, BRNC, GTIV Highest % Of Daily Trading Volume


Published on 2009-09-17 09:02:42, Last Modified on 2010-12-22 14:44:46 - WOPRAI
  Print publication without navigation


September 17, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Wednesday, September 16th, 2009 and come to the following statistical conclusions. There were 6,769 stocks with daily short volume reported and total NASDAQ trading volume of 2,078,016,956 shares. Total Daily Short Volume was 1,060,132,464 shares. 51.01% of all trading on the NASDAQ Wednesday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Micromet (NASDAQ: MITI), Private Media Group (NASDAQ: PRVT), Magma Design Automation (NASDAQ: LAVA), Authentidate Holding (NASDAQ: ADAT), Bronco Drilling (NASDAQ: BRNC) and Gentiva Health Services (NASDAQ: GTIV). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20090916 MITI 133,870 149,947 Q 89.28%

20090916 PRVT 98,000 113,061 Q 86.68%

20090916 LAVA 103,916 125,396 Q 82.87%

20090916 ADAT 88,775 110,734 Q 80.17%

20090916 BRNC 175,242 224,565 Q 78.04%

20090916 GTIV 122,818 159,069 Q 77.21%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa� naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company, engages in the development and sale of antibodies for the treatment of cancer, inflammation, and autoimmune diseases. The companya�s products under development pipeline using BiTE antibody technology platform include MT103, which is evaluated in a Phase II clinical trial for the treatment of acute lymphoblastic leukemia and in a Phase I clinical trial for the treatment of non-Hodgkina�s lymphoma; and MT110 that is tested in a Phase I clinical trial for the treatment of patients with solid tumors. Its products also include adecatumumab (MT201), a recombinant human monoclonal antibody in Phase Ib clinical trial to treat patients with metastatic breast cancer; and MT293, a humanized anti-metastatic and anti-angiogenic monoclonal antibody in a Phase I clinical trial for the treatment of patients with solid tumors. In addition, the companya�s pre-clinical stage products include MT203, a human antibody to treat rheumatoid arthritis, asthma, psoriasis, and multiple sclerosis; MT228, a product for melanoma; MT204, a humanized antibody to treat rheumatoid arthritis, asthma, acute transplant rejection, uveitis, psoriasis, and multiple sclerosis; MT111 that binds to carcinoembryonic antigen, which is expressed in various solid tumors, including colorectal carcinoma, gastric carcinoma, lung adenocarcinoma, mucinous ovarian carcinoma, and endometrial adenocarcinoma; MCSP BiTE antibody to treat melanoma; CD33 BiTE antibody to treat acute myelogenic lymphoma; HER2 BiTE antibody to treat breast cancer; and EGFR BiTE antibody to treat solid tumors. The company has license agreements and collaborations with Biovation Limited; Enzon Pharmaceuticals, Inc.; MedImmune LLC; Merck Serono Biopharmaceuticals S.A.; TRACON Pharmaceuticals, Inc.; Nycomed A/S; and Morphotek, Inc. Micromet, Inc. is headquartered in Bethesda, Maryland.

Private Media Group, Inc. (NASDAQ: PRVT), together with its subsidiaries, provides adult media content for various media platforms. The company processes still photography and motion picture images into products suitable for media formats, such as print publications, DVDs, and electronic media content for Internet, mobile, and broadcasting distribution. It distributes its adult media content directly and through a network of local affiliates and independent distributors, as well as through various channels, including newsstands, video rental stores, travel retail, and adult bookstores; mail order catalogues; cable, satellite, and hotel television programming; over the Internet via proprietary Web sites and broadband delivery services; and wireless telephony. The company also markets and distributes branded leisure and novelty products oriented to the adult entertainment lifestyle. In addition, it offers services through Internet, which includes video on demand, live sex chat, adult personals, and e-commerce, as well as licenses its trademarks and proprietary adult media content for use on the Web sites of other companies. Further, the company provides mobile content program that comprise games and rich-media mobile downloads, including multimedia messaging service, wallpapers, screensavers, video clips, and video streaming. Additionally, it publishes X-rated magazines consisting of Private, Pirate, Triple X, and Private Sex, which are distributed through newsstands and other retail outlets. As of December 31, 2008, the companya�s movie library contained 1,170 movie titles. It sells its products in the United States, Gibraltar, Cyprus, Sweden, Spain, France, Benelux, and Canada. The company was formerly known as Glacier Investment Company, Inc. and changed its name to Private Media Group, Inc. in November 1997. Private Media Group, Inc. was founded in 1980 and is headquartered in Barcelona, Spain.

Magma Design Automation, Inc. (NASDAQ: LAVA) provides electronic design automation software products and related services. The companya�s products comprise a digital integrated solution for the chip development cycle, from initial design through physical implementation. Its software enables chip designers to reduce the time it takes to design and produce integrated circuits used in the communications, computing, consumer electronics, networking, and semiconductor industries. Magma Design Automationa�s Blast and Talus family of products, and Quartz family of sign-off and verification tools combine into one integrated chip design and verification flow, from what traditionally had been separate logic design, physical design, and analysis and sign-off processes. The companya�s Titan platform for custom integrated chip design provides an integrated chip-finishing solution for mixed-signal designs. It also provides consulting and training services to its customers, as well as post-contract support or maintenance service for its products. Magma Design Automation licenses its products to the semiconductor manufacturers and electronic products manufacturers worldwide. The company was founded in 1977 and is headquartered in San Jose, California.

Authentidate Holding Corp. (NASDAQ: ADAT), through its subsidiaries, provides secure workflow management software and Web-based services. Its offerings incorporate security technologies, such as rules based electronic forms, intelligent routing and transaction management, electronic signing, content authentication, identity credentialing and verification, and Web and fax-based communication capabilities to electronically facilitate secure and trusted workflows. The companya�s products include Inscrybe Healthcare, a secure Web-based information network that enables users in the healthcare industry to exchange time-sensitive information via the Web or fax; Inscrybe Office, a Web-based service, which enables to sign, seal, and confirm receipt of important documents over the Web; and USPS EPM Service, which enables a user to have a digital record of a transaction created and stored by a trusted third party. It also develops and sells software applications that provide electronic signature and time stamping capabilities for various corporate processes, including electronic billing and archiving solutions. In addition, Authentidate Holding Corp. offers a patent pending content authentication technology in the form of the United States Postal Service Electronic Postmark. The company sells its software and Web-based services primarily through direct sales and resellers. It operates in the United States and Germany. The company, formerly known as Bitwise Designs, Inc., was founded in 1985 and is based in Berkeley Heights, New Jersey.

Bronco Drilling Company, Inc. (NASDAQ: BRNC) provides contract land drilling and workover services to oil and natural gas exploration and production companies in the United States and Mexico. As of February 28, 2009, it owned a fleet of 56 land drilling rigs operated in Oklahoma, Texas, Colorado, Utah, North Dakota, Louisiana, and Mexico; owned a fleet of 61 workover rigs operated in Oklahoma, Texas, Kansas, Colorado, Louisiana, and New Mexico; and owned a fleet of 63 trucks and related transportation equipment to transport drilling rigs to and from drilling sites. It markets its drilling and workover rigs through employee marketing representatives. The company was founded in 2001 and is headquartered in Edmond, Oklahoma.

Gentiva Health Services, Inc. (NASDAQ: GTIV) provides home health services in the United States. The companya�s Home Health segment offers skilled nursing and therapy services, paraprofessional nursing services, and homemaker services primarily to adult and elderly patients through licensed and Medicare-certified agencies. This segment also provides its services through specialty programs comprising Gentiva Orthopedics, which offers individualized home orthopedic rehabilitation services; Gentiva Safe Strides that provides therapies for patients with balance issues; and Gentiva Cardiopulmonary, which helps patients and their physicians manage heart and lung health in a home-based environment. In addition, this segment provides services through Gentiva Neurorehabilitation that offers therapies for patients with neurological injury; and Gentiva Senior Health, which addresses the needs of patients with age-related diseases, as well as Rehab Without Walls unit that provides neurorehabilitation therapies for patients with traumatic brain injury, cerebrovascular accident injury, and acquired brain injury. The companya�s All Other segment offers hospice services; respiratory therapy services for patients with asthma, chronic obstructive pulmonary diseases, cystic fibrosis, and other respiratory conditions; home medical equipment, such as hospital beds, wheelchairs, ambulatory aids, bathroom aids, patient lifts, and rehabilitation equipment; infusion therapy services comprising enteral nutrition, antibiotic therapy, total parenteral nutrition, pain management, chemotherapy, patient education and training, and nutrition management; and consulting services. Gentiva Health Services was founded in 1999 and is headquartered in Atlanta, Georgia.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net

Contributing Sources